Sponsor:
Exero Medical Ltd.
Code:
NCT07337590
Conditions
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
xBar™ System
Brief summary:
Conditions
Colorectal Cancer
Study ID
NCT07337590
Start date
Mar 10, 2026
Status verified date
Jun, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
experimental: Interventional Cohort
no intervention: Historical Control Cohort
Interventions
xBar™ System
Primary outcome measure
Central contacts
Ruth Stone
ruth.stone@exeromedical.comLocations
University of Louisville Hospital
Recruiting
Louisville, Kentucky, United States, 40202
Contacts
Kiel Carson Butterfield
kiel.carsonbutterfield@louisville.eduPrincipal Investigator:
Sandra Kavalukas, MD
Johns Hopkins University
Recruiting
Baltimore, Maryland, United States, 21287
Contacts
Jodie Frost
jfrost17@jhmi.eduPrincipal Investigator:
Andrea Bafford, MD, FACS, FASCRS
Bryan Medical Center
Recruiting
Lincoln, Nebraska, United States, 68506
Contacts
Kristin Williams
kristin.williams@bryanhealth.orgPrincipal Investigator:
Michael Jobst, MD
Weill Cornell Medicine Colon and Rectal Surgery
Recruiting
New York, New York, United States, 10021
Contacts
Principal Investigator:
Mehraneh D Jafari, MD
Allegheny Health Network
Recruiting
Pittsburgh, Pennsylvania, United States, 15212
Contacts
Principal Investigator:
James McCormick, MD
Sponsor
Exero Medical Ltd.
Last update posted
Jun 16, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Exero Medical Ltd. on 2026-06-16.